RLXXF OTC

RELX PLC delivers advanced data-driven analytical insights and strategic decision-making instruments to a diverse global customer base, encompassing professional and commercial enterprises across North America, Europe, and other international regions. The company's operations are divided into four primary divisions: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. Its Risk segment provides sophisticated analytical and evaluative tools. These tools integrate a wealth of public and industry-specific content with cutting-edge technology and algorithms, enabling clients to effectively assess and anticipate potential dangers. The Scientific, Technical & Medical division furnishes critical information and analytical capabilities, empowering institutions and professionals to drive scientific advancements and improve healthcare outcomes. Through its Legal arm, RELX offers vital legal, regulatory, and business intelligence, alongside analytical services, designed to support informed decision-making and enhance productivity for its clientele. Finally, the Exhibitions segment orchestrates events that expertly blend in-person interactions with digital technologies and data resources, allowing participants to explore market trends, identify suppliers, and finalize transactions. Established in 1903 and headquartered in London, United Kingdom, the organization was previously known as Reed Elsevier PLC, adopting its current name, RELX PLC, in July 2015.